Report Detail
Global Hemoglobinopathies Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM3796972 |
- 02 July, 2024 |
- Global |
- 85 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Hemoglobinopathies market size was valued at USD 282.5 million in 2023 and is forecast to a readjusted size of USD 379.4 million by 2030 with a CAGR of 4.3% during review period.
Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Hemoglobinopathies industry chain, the market status of Blood Testing (Blood Transfusion, Iron Chelation Therapy), Genetic Testing (Blood Transfusion, Iron Chelation Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hemoglobinopathies.
Regionally, the report analyzes the Hemoglobinopathies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hemoglobinopathies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hemoglobinopathies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hemoglobinopathies industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Transfusion, Iron Chelation Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hemoglobinopathies market.
Regional Analysis: The report involves examining the Hemoglobinopathies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hemoglobinopathies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hemoglobinopathies:
Company Analysis: Report covers individual Hemoglobinopathies players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hemoglobinopathies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Blood Testing, Genetic Testing).
Technology Analysis: Report covers specific technologies relevant to Hemoglobinopathies. It assesses the current state, advancements, and potential future developments in Hemoglobinopathies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hemoglobinopathies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hemoglobinopathies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Blood Transfusion
Iron Chelation Therapy
Bone Marrow Transplant
Others
Market segment by Application
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others
Market segment by players, this report covers
Gamida Cell
Alnylam Pharmaceuticals
Sanofi
Sangamo Therapeutics Inc.
Global Blood Therapeutics
Bluebird Bio
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Celgene Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hemoglobinopathies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hemoglobinopathies, with revenue, gross margin and global market share of Hemoglobinopathies from 2019 to 2024.
Chapter 3, the Hemoglobinopathies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hemoglobinopathies market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hemoglobinopathies.
Chapter 13, to describe Hemoglobinopathies research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Hemoglobinopathies
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Hemoglobinopathies by Type
- 1.3.1 Overview: Global Hemoglobinopathies Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Hemoglobinopathies Consumption Value Market Share by Type in 2023
- 1.3.3 Blood Transfusion
- 1.3.4 Iron Chelation Therapy
- 1.3.5 Bone Marrow Transplant
- 1.3.6 Others
- 1.4 Global Hemoglobinopathies Market by Application
- 1.4.1 Overview: Global Hemoglobinopathies Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Blood Testing
- 1.4.3 Genetic Testing
- 1.4.4 Pre-Implantation Genetic Diagnosis (PGD)
- 1.4.5 Others
- 1.5 Global Hemoglobinopathies Market Size & Forecast
- 1.6 Global Hemoglobinopathies Market Size and Forecast by Region
- 1.6.1 Global Hemoglobinopathies Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Hemoglobinopathies Market Size by Region, (2019-2030)
- 1.6.3 North America Hemoglobinopathies Market Size and Prospect (2019-2030)
- 1.6.4 Europe Hemoglobinopathies Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Hemoglobinopathies Market Size and Prospect (2019-2030)
- 1.6.6 South America Hemoglobinopathies Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Hemoglobinopathies Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Gamida Cell
- 2.1.1 Gamida Cell Details
- 2.1.2 Gamida Cell Major Business
- 2.1.3 Gamida Cell Hemoglobinopathies Product and Solutions
- 2.1.4 Gamida Cell Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Gamida Cell Recent Developments and Future Plans
- 2.2 Alnylam Pharmaceuticals
- 2.2.1 Alnylam Pharmaceuticals Details
- 2.2.2 Alnylam Pharmaceuticals Major Business
- 2.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Product and Solutions
- 2.2.4 Alnylam Pharmaceuticals Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Hemoglobinopathies Product and Solutions
- 2.3.4 Sanofi Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Sanofi Recent Developments and Future Plans
- 2.4 Sangamo Therapeutics Inc.
- 2.4.1 Sangamo Therapeutics Inc. Details
- 2.4.2 Sangamo Therapeutics Inc. Major Business
- 2.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Product and Solutions
- 2.4.4 Sangamo Therapeutics Inc. Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Sangamo Therapeutics Inc. Recent Developments and Future Plans
- 2.5 Global Blood Therapeutics
- 2.5.1 Global Blood Therapeutics Details
- 2.5.2 Global Blood Therapeutics Major Business
- 2.5.3 Global Blood Therapeutics Hemoglobinopathies Product and Solutions
- 2.5.4 Global Blood Therapeutics Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Global Blood Therapeutics Recent Developments and Future Plans
- 2.6 Bluebird Bio
- 2.6.1 Bluebird Bio Details
- 2.6.2 Bluebird Bio Major Business
- 2.6.3 Bluebird Bio Hemoglobinopathies Product and Solutions
- 2.6.4 Bluebird Bio Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Bluebird Bio Recent Developments and Future Plans
- 2.7 Emmaus Life Sciences Inc.
- 2.7.1 Emmaus Life Sciences Inc. Details
- 2.7.2 Emmaus Life Sciences Inc. Major Business
- 2.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Product and Solutions
- 2.7.4 Emmaus Life Sciences Inc. Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Emmaus Life Sciences Inc. Recent Developments and Future Plans
- 2.8 Prolong Pharmaceuticals
- 2.8.1 Prolong Pharmaceuticals Details
- 2.8.2 Prolong Pharmaceuticals Major Business
- 2.8.3 Prolong Pharmaceuticals Hemoglobinopathies Product and Solutions
- 2.8.4 Prolong Pharmaceuticals Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Prolong Pharmaceuticals Recent Developments and Future Plans
- 2.9 Celgene Corporation
- 2.9.1 Celgene Corporation Details
- 2.9.2 Celgene Corporation Major Business
- 2.9.3 Celgene Corporation Hemoglobinopathies Product and Solutions
- 2.9.4 Celgene Corporation Hemoglobinopathies Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Celgene Corporation Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Hemoglobinopathies Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Hemoglobinopathies by Company Revenue
- 3.2.2 Top 3 Hemoglobinopathies Players Market Share in 2023
- 3.2.3 Top 6 Hemoglobinopathies Players Market Share in 2023
- 3.3 Hemoglobinopathies Market: Overall Company Footprint Analysis
- 3.3.1 Hemoglobinopathies Market: Region Footprint
- 3.3.2 Hemoglobinopathies Market: Company Product Type Footprint
- 3.3.3 Hemoglobinopathies Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Hemoglobinopathies Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Hemoglobinopathies Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Hemoglobinopathies Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Hemoglobinopathies Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Hemoglobinopathies Consumption Value by Type (2019-2030)
- 6.2 North America Hemoglobinopathies Consumption Value by Application (2019-2030)
- 6.3 North America Hemoglobinopathies Market Size by Country
- 6.3.1 North America Hemoglobinopathies Consumption Value by Country (2019-2030)
- 6.3.2 United States Hemoglobinopathies Market Size and Forecast (2019-2030)
- 6.3.3 Canada Hemoglobinopathies Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Hemoglobinopathies Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Hemoglobinopathies Consumption Value by Type (2019-2030)
- 7.2 Europe Hemoglobinopathies Consumption Value by Application (2019-2030)
- 7.3 Europe Hemoglobinopathies Market Size by Country
- 7.3.1 Europe Hemoglobinopathies Consumption Value by Country (2019-2030)
- 7.3.2 Germany Hemoglobinopathies Market Size and Forecast (2019-2030)
- 7.3.3 France Hemoglobinopathies Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Hemoglobinopathies Market Size and Forecast (2019-2030)
- 7.3.5 Russia Hemoglobinopathies Market Size and Forecast (2019-2030)
- 7.3.6 Italy Hemoglobinopathies Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Hemoglobinopathies Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Hemoglobinopathies Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Hemoglobinopathies Market Size by Region
- 8.3.1 Asia-Pacific Hemoglobinopathies Consumption Value by Region (2019-2030)
- 8.3.2 China Hemoglobinopathies Market Size and Forecast (2019-2030)
- 8.3.3 Japan Hemoglobinopathies Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Hemoglobinopathies Market Size and Forecast (2019-2030)
- 8.3.5 India Hemoglobinopathies Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Hemoglobinopathies Market Size and Forecast (2019-2030)
- 8.3.7 Australia Hemoglobinopathies Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Hemoglobinopathies Consumption Value by Type (2019-2030)
- 9.2 South America Hemoglobinopathies Consumption Value by Application (2019-2030)
- 9.3 South America Hemoglobinopathies Market Size by Country
- 9.3.1 South America Hemoglobinopathies Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Hemoglobinopathies Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Hemoglobinopathies Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Hemoglobinopathies Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Hemoglobinopathies Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Hemoglobinopathies Market Size by Country
- 10.3.1 Middle East & Africa Hemoglobinopathies Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Hemoglobinopathies Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Hemoglobinopathies Market Size and Forecast (2019-2030)
- 10.3.4 UAE Hemoglobinopathies Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Hemoglobinopathies Market Drivers
- 11.2 Hemoglobinopathies Market Restraints
- 11.3 Hemoglobinopathies Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Hemoglobinopathies Industry Chain
- 12.2 Hemoglobinopathies Upstream Analysis
- 12.3 Hemoglobinopathies Midstream Analysis
- 12.4 Hemoglobinopathies Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Hemoglobinopathies. Industry analysis & Market Report on Hemoglobinopathies is a syndicated market report, published as Global Hemoglobinopathies Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Hemoglobinopathies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
